Elagolix Sodium; NBI 56418NA; NBI-56418 sodium

规格	库存	目录价	会员专享价	数量
暂无牌价信息，您可以发送询价，我们会尽快给你回复。

规格

库存

目录价

会员专享价

数量

暂无牌价信息，您可以发送询价，我们会尽快给你回复。

基本信息

英文名称	Elagolix Sodium; NBI 56418NA; NBI-56418 sodium
中文名称	噁拉戈利钠
CAS号	832720-36-2
分子式	C32H29F5N3NaO5
分子量	653.57
外观	White to light yellow powder
储存条件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

产品详情

Elagolix sodium (NBI56418; ABT-620; Orilissa), the sodium salt of Elagolix, is an orally bioavailable and small molecule antagonist of the gonadotropin-releasing hormone receptor (GnRHR) (KD = 54 pM) approved on 7/23/2018 by FDA for the management of moderate to severe pain associated with endometriosis. Elagolix is a short-acting GnRH antagonist that suppresses ovarian estrogen production in a dose-dependent manner, meaning that higher doses result in full suppression while lower doses only cause partial suppression. Elagolix's non-peptide structure and oral bioavailability make it the leader of a new class of GnRH inhibitors known as second-generation inhibitors.

噁拉戈利钠

Elagolix Sodium; NBI 56418NA; NBI-56418 sodium

化学品安全说明书(MSDS)